Verzenio Tablet
Product Images NDC 0002-4815

14 FDA label images from Eli Lilly And Company · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Verzenio (NDC 0002-4815). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Abemaciclib Structure (Verzenio Pi Chem Struct V2)

Abemaciclib Structure (Verzenio Pi Chem Struct V2)
Chemical structure of abemaciclib, the active ingredient in Verzenio tablets. The diagram shows a detailed molecular formula with multiple rings, nitrogen and fluorine atoms, representing the compound's chemical composition.*
FDA Label Image

Figure 1 (Verzenio Pi F1 V6)

Figure 1 (Verzenio Pi F1 V6)
A Kaplan-Meier survival curve chart depicting invasive disease-free survival probability (%) over time in months (0 to 60). It compares two groups: patients treated with Verzenio (abemaciclib) plus Tamoxifen or Aromatase Inhibitors (solid black line) versus those treated with Tamoxifen or Aromatase Inhibitors alone (dashed gray line). The chart includes censored observations and patient risk numbers at multiple time points.*
FDA Label Image

Figure 2 (Verzenio Pi F2 V4)

Figure 2 (Verzenio Pi F2 V4)
A Kaplan-Meier curve graph showing progression-free survival probability (%) over time (months) comparing VERZENIO plus NSAI (solid line) and placebo plus NSAI (dashed line). The graph includes censored observations marked with vertical ticks and a patient risk table at various time points for each treatment group.*
FDA Label Image

Figure 3 (Verzenio Pi F3 V3)

Figure 3 (Verzenio Pi F3 V3)
A Kaplan-Meier survival curve chart depicting progression-free survival probability (%) over time in months for two groups: VERZENIO plus fulvestrant (solid line, N=446) and placebo plus fulvestrant (dashed line, N=223). The chart includes censored observations marked on the curves and a table showing number of patients at risk at various time points up to 27 months.*
FDA Label Image

Figure 4 (Verzenio Pi F4 V3)

Figure 4 (Verzenio Pi F4 V3)
A Kaplan-Meier survival probability chart comparing VERZENIO plus fulvestrant versus placebo plus fulvestrant over time in months. The y-axis shows survival probability percentage, and the x-axis shows time from 0 to 57 months. Two curves represent survival rates for 446 patients on VERZENIO and 223 on placebo, with censored observations marked. Patient counts at risk decrease over time for both groups.*
FDA Label Image

Figure (Verzenio Pi F5 V1)

Figure (Verzenio Pi F5 V1)
A Kaplan-Meier survival curve comparing progression-free survival percentage over time in months between two groups: one treated with imlunestrant plus Verzenio and one with imlunestrant alone. The graph includes numbers at risk for each group at various time points up to 24 months.*
FDA Label Image

Package Carton – Verzenio 50 mg 14ct (Verzenio 50mg 14ct 033 04)

Package Carton – Verzenio 50 mg 14ct (Verzenio 50mg 14ct 033 04)
Verzenio 50 mg tablets carton label containing 14 tablets for oral use. The label includes instructions for taking Verzenio tablets twice daily and storage information. Marketed by Lilly USA, LLC, this prescription drug contains abemaciclib as the active ingredient. The packaging has a pull-out insert for opening and space for pharmacy label attachment.*
FDA Label Image

Package Carton – Verzenio 50 mg 14ct (Verzenio 50mg 14ct 057 01)

Package Carton – Verzenio 50 mg 14ct (Verzenio 50mg 14ct 057 01)
Verzenio (abemaciclib) 50 mg tablets packaging label includes information for a 7-day supply with fourteen 50 mg tablets. The label provides administration instructions, dosing schedule (morning and evening doses), and storage conditions. Manufactured by Eli Lilly and Company, the label features a pull-out opening mechanism with step-by-step opening instructions. The package also includes safety warnings and a barcode.*
FDA Label Image

Package Carton – Verzenio 100 mg 14ct (Verzenio 100mg 14ct 031 04)

Package Carton – Verzenio 100 mg 14ct (Verzenio 100mg 14ct 031 04)
Verzenio (abemaciclib) tablets 100 mg dose packaging label for a 7-day supply of 14 tablets. The label includes dosing instructions to take one 100 mg tablet twice daily, morning and evening. It is marketed by Eli Lilly and Company and includes storage instructions, a barcode, and pharmacy label attachment area. The label also features opening instructions for the dose pack.*
FDA Label Image

Package Carton – Verzenio 100 mg 14ct (Verzenio 100mg 14ct 058 01)

Package Carton – Verzenio 100 mg 14ct (Verzenio 100mg 14ct 058 01)
Verzenio (abemaciclib) 100 mg tablets Dose Pack carton, containing fourteen 100 mg tablets for a 7-day supply. The label includes dosage instructions to take 100 mg twice daily and storage conditions. The labeler is Eli Lilly and Company.*
FDA Label Image

Package Carton – Verzenio 150 mg 14ct (Verzenio 150mg 14ct 029 04)

Package Carton – Verzenio 150 mg 14ct (Verzenio 150mg 14ct 029 04)
Verzenio 150 mg tablets packaging label by Eli Lilly and Company. The label indicates a 7-day supply with fourteen 150 mg tablets of abemaciclib. It includes detailed dosing instructions for morning and evening doses, storage information, and opening instructions for the dose pack. The label features the Verzenio brand and abemaciclib generic name along with manufacturer details and a barcode.*
FDA Label Image

Package Carton – Verzenio 150 mg 14ct (Verzenio 150mg 14ct 059 01)

Package Carton – Verzenio 150 mg 14ct (Verzenio 150mg 14ct 059 01)
Verzenio (abemaciclib) 150 mg tablets packaging label for a 7-day supply containing 14 tablets. The label includes dosage instructions, manufacturer Eli Lilly and Company, storage information, and a security button opening mechanism. The label is primarily white with blue and red accents, and states the product is prescription only.*
FDA Label Image

Package Carton – Verzenio 200 mg 14ct (Verzenio 200mg 14ct 027 04)

Package Carton – Verzenio 200 mg 14ct (Verzenio 200mg 14ct 027 04)
Packaging label for Verzenio (abemaciclib) tablets 200 mg dose by Eli Lilly and Company. The label indicates a 7-day supply containing fourteen 200 mg tablets. Key instructions for taking the tablets, including morning and evening doses, are displayed, along with storage information and opening instructions. The label includes manufacturer details and barcode.*
FDA Label Image

Package Carton – Verzenio 200 mg 14ct (Verzenio 200mg 14ct 060 01)

Package Carton – Verzenio 200 mg 14ct (Verzenio 200mg 14ct 060 01)
Packaging label for Verzenio (abemaciclib) tablets, 200 mg dose, oral tablet form. The label indicates a 7-day supply containing fourteen 200 mg tablets, manufactured by Eli Lilly and Company. It includes dosage instructions, handling directions, storage conditions, and a barcode. The label also features the Verzenio logo and prescribing information references.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.